KEY NY CLINICAL TRIALS


RCD US has announced that it will be assisting with key ependymoma research coming out of New York. The Weill Cornell Medical Centre is currently working on ‘personalised clinical trials’ for each patient, a study which is much akin to another program we support: personalised medicine at the Children’s Cancer Institute in Sydney. Personalised clinical trials involve deep genomic sequencing of different tumours to look at their evolution and response to different therapies.

Much like the RCD Fund, the Weill Cornell Medical Centre believes that treatment plans should consider the whole child – not just the disease, with an emphasis on the rehabilitation and quality of life of their patients.

Our commitment to help fund key paediatric ependymoma extends beyond Australia as we continue to build our network of leading researchers in the fields of neurology and oncology. Our recent connections with the Children’s Cancer Centre Foundation, the Children’s Cancer Institute, and the Weill Cornell Medical Centre are based on the firm belief that it takes a collaborative effort to save lives.

 

More about the centre can be found here.